Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease? - Wikidata - awgldk - TriplyDB

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

http://www.wikidata.org/entity/Q48819917

about

New Directions in Gaucher Disease.

P2860

Q38905996-1981FFD9-E7C8-4A31-A64C-3A66C9F6A034

P2860

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

http://www.wikidata.org/entity/Q48819917

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

@en

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

@nl

type

label

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

@en

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

@nl

prefLabel

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

@en

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

@nl

P1433

Q48819917-FB821D4B-1FCE-4FD1-B6BD-C115359C56A4

P1476

Q48819917-B3A13ECC-7063-412D-906C-93B2E6A1615E

P2093

Q48819917-71862377-16CD-46E8-8C8E-D54C2B0EBBE3

P2860

Q48819917-14333997-B5CF-4726-80A2-FF5BA8B989AA

Q48819917-23EC275F-2007-483D-B151-DBF5173C8CB7

Q48819917-294FCE5B-DFE8-438A-87FF-8BD80420E48B

Q48819917-4AFF144B-285A-4BD6-9336-34AA9CB97FF5

Q48819917-51408957-A49F-4A1F-9FF6-122F44AB7AC1

Q48819917-68770854-8934-4529-916A-CBFB844EBF91

Q48819917-77D08C2C-41A9-4155-AF64-33DEF350F9A3

Q48819917-88357A27-7630-42EE-B790-77D2DB4777B6

Q48819917-894E0120-B60F-4845-860E-6BD61635B97D

Q48819917-8CF0AD54-5F80-4990-9DB7-257468D3D821

P304

Q48819917-7997797A-BD96-4C62-BC1E-23B414E99A7F

P31

Q48819917-628DE5B0-0B34-4F02-9C8C-C2790213755C

Q48819917-cd9a0975-72e9-43c0-9f0d-4aa6068bf131

P356

Q48819917-A453A1A7-7D9B-4855-9840-F85F53D8145B

P433

Q48819917-39DD09A1-9DE0-420A-B84A-CFF5FDE12EB3

P478

Q48819917-982392C4-BB4D-4C39-BB31-BA525549BDEA

P50

Q48819917-003D2B29-2D6F-4F91-BDF2-457E5CE7CC9E

Q48819917-CFE50485-FA1C-4A3B-9569-330F009CA806

P577

Q48819917-A6F301B7-2919-472D-9D68-ED3E3BD56E47

P698

Q48819917-104E3F8C-9EDE-48E3-865B-92B8A6205246

P356

P1433

Future Medicinal Chemistry

P1476

Glucocerebrosidase inhibitors: future drugs for the treatment of Gaucher disease?

@en

P2093

Ana Trapero

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological chaperoning: a primer on mechanism and pharmacology

Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease

Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase

Gaucher disease and its treatment options.

Gaucher disease: Perspectives on a prototype lysosomal disease.

Phenotype, diagnosis, and treatment of Gaucher's disease.

The cell biology of lysosomal storage disorders.

Gaucher disease: complexity in a "simple" disorder.

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.

Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics.

P304

975-978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.14.41

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Amadeu Llebaria

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25068980

http://www.w3.org/2001/XMLSchema#string